Invesco Nasdaq Biotechnology ETF
| Fund Name: |
| Invesco Nasdaq Biotechnology ETF |
| Issuer: |
| Invesco |
| Total Net Assets: |
| $19,104,500 |
| Inception: |
| 06/11/2021 |
| Related Index: |
| XNBI |
| ETF Category: |
| Technology |
| Expense Ratio: |
| 0.19% |
|
| Net Asset Value: |
| $20.11 |
| Recent NAV Premium: |
| 0.00% |
| NAV Symbol: |
| IBBQ.NV |
| Number of Holdings: |
| 271 |
| Annualized Yield: |
| 0.58% |
| Annualized Distribution: |
| 0.116 |
| IBBQ Dividend History » |
|
| Stock |
Weight |
Amount |
| Regeneron Pharmaceuticals |
8.07% |
$1,541,330 |
| Gilead Sciences |
7.80% |
$1,490,950 |
| Vertex Pharmaceuticals |
7.72% |
$1,474,061 |
| Amgen |
7.03% |
$1,343,604 |
| Moderna |
5.76% |
$1,099,924 |
| List of all 271 stocks held by IBBQ
» |
|
Buy (3.16 out of 4)
32nd percentile
|
IBBQ | Invesco Nasdaq Biotechnology ETF | ETF Channel | www.ETFChannel.com
Copyright © 2010 - 2023, All Rights Reserved
Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use
and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20
minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.
ETFChannel.com
Free IBBQ Email Alerts:
